Subcutaneous anti-HER2 antibody formulations and uses thereof

US12427193B2 · 09/30/2025

FIG. 1 · Sheet 1

Download patent PDF Write about this patent

The present invention relates to a highly concentrated, stable pharmaceutical formulation of a pharmaceutically active anti-HER2 antibody, such as e.g. Trastuzumab (HERCEPTIN™), Pertuzumab or T-DM1, or a mixture of such antibody molecules for subcutaneous injection. In particular, the present …

Full text

1 sections

Official name

Subcutaneous anti-HER2 antibody formulations and uses thereof

Publication number

US12427193B2

Inventor / creator

Michael Adler

Assignee / owner

Genentech, Inc.

Filing

12/20/2024

Publication

09/30/2025

Expiry

12/20/2044

Status

ACTIVE

Open Google Patents →

No articles yet — metadata is still available from the registry.

Comments

0 replies · cite patents with ^

Join the discussion

Continue with Google

No comments yet.